by Amanda Finburg | Jul 11, 2022 | News
Researchers have launched a new study to improve our understanding of monkeypox disease. The first patients have now been recruited at Hôpitaux Universitaires de Genève (HUG) in Switzerland. Monkeypox is a relatively rare disease. In most patients it causes a painful...
by Liliana Resende | Aug 25, 2021 | News
With more than 16 million confirmed cases, it is safe to say that Brazil is one of the most affected countries by the COVID-19 pandemic. With this in mind, Fernando Bozza (Oswaldo Cruz Foundation (Fiocruz), Brazil) ISARIC’s member network Principal Investigator,...
by Liliana Resende | Aug 11, 2021 | News
A group of researchers started this project with the aims of understanding what are the core outcomes for patients living with Long COVID. The World Health Organization (WHO) recently called countries to prioritise recognition, rehabilitation and research for the...
by Liliana Resende | Jul 16, 2021 | News
On its 10th anniversary, University of Oxford’s ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) demonstrates the crucial role of global preparedness and collaboration for advancing knowledge on infectious disease pandemics. COVID-19...
by Liliana Resende | Jul 14, 2021 | News
Researchers from ISARIC (International Severe Acute Respiratory and emerging Infection Consortium) paediatric Long Covid working group in the UK, Sechenov University and Z.A. Bashlyaeva Children’s Municipal Clinical Hospital in Russia ran the largest study to date on...
by Liliana Resende | Jul 8, 2021 | News
Ribavirin is the only available Lassa fever–specific treatment and has been used routinely for over 25 years. However, Ribavirin is not licensed for Lassa fever, its mechanism of action is unclear, it’s expensive and hard to source, and it has well-known...
